• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    CStone Shares Ph1/2 Data For CS2009 Trispecific Antibody

    PR NEWSWIRE

    Cstone Boosts Global Presence And Advances Innovation Pipeline

    PR NEWSWIRE

    Cstone Gets MHRA Nod For Sugemalimab In Stage III NSCLC In UK

    PR NEWSWIRE

    CStone Advances Trispecific Antibody CS2009 To Phase II Trial

    PR NEWSWIRE

    ACAAI 2025: CS2015 Bispecific Antibody Debuts Globally

    PR NEWSWIRE

    Cstone Reveals Phase I Results For CS2009 Trispecific Antibody

    PR NEWSWIRE

    CStone Presents Preclinical Results of CS2011, CS5007, CS5005

    PR NEWSWIRE

    CStone Reveals Preclinical Findings of CS2009 at 2025 AACR

    PR NEWSWIRE

    CStone to Showcase Five Latest Research Achievements at AACR 2025

    PR NEWSWIRE

    CStone Seeks New Indication for Sugemalimab in Stage III Non-Smal

    PR NEWSWIRE

    CStone Doses First Patient In Ph1 Trial Of CS2009 (PD-1/VEGF/CTLA-4)

    PR NEWSWIRE

    CStone Announces GEMSTONE-303 Study Results for Sugemalimab in JAMA

    PR NEWSWIRE

    CStone`s Cejemly Included as 1st-Line NSCLC Combo in ESMO Guideline

    PR NEWSWIRE

    CStone Partners with SteinCares to Market Sugemalimab in America

    PR NEWSWIRE

    CStone Submits Clinical Trial Application for CS2009 in Australia

    PR NEWSWIRE

    CStone: CS5001 Shows Safety, Efficacy in Advanced Lymphoma Patients

    PR NEWSWIRE

    CStone MHRA Approves Sugemalimab for First-Line NSCLC in UK

    PR NEWSWIRE

    CStone`s Sugemalimab Approved In EU For First-Line NSCLC Treatment

    PR NEWSWIRE

    EMA CHMP supports CStone’s sugemalimab for metastatic NSCLC

    PHARMACEUTICAL TECHNOLOGY

    CStone gets a win for sugemalimab in oesophageal cancer

    PHARMAPHORUM

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.